TCG Labs Soleil Says Three Programs Are Entering First-in-Human Trials
TCG Labs Soleil reports that three programs are entering first-in-human clinical trials across oncology and cardiovascular disease.
Related stories
Merck Raises Annual Profit Forecast After Topping Q3 Results
Merck shares rose after the company raised its annual profit forecast and reported Q3 results that topped expectations.
M impact | EQUITY | Oct 29, 2026, 01:59 PM UTC
Butterfly Network Q3 Loss Narrows, Revenue Rises; 2026 Outlook Raised
Butterfly Network reported a narrower adjusted loss and higher revenue in Q3, and raised its 2026 revenue outlook.
M impact | EQUITY | Oct 29, 2026, 01:58 PM UTC
Angang Steel Reports Q3 Net Loss of 2.0 Billion Yuan
M impact | EQUITY | Oct 29, 2026, 01:58 PM UTC
Proto Labs Shares Fall 7.6% After Q3 Results and Q4 Guidance
Proto Labs shares were down 7.6% in early Thursday trading. The headline reports higher Q3 adjusted earnings and revenue and that Q4 guidance was set.
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
Bank of Jordan Q3 Profit Attributable to Shareholders Is 9.8 Million Dinars
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
Alamos Gold Q3 2026 Earnings Call Begins
Alamos Gold's quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC